Table 6.
Biomarker | Sensing Platform | Detection Method | LODa | Detection Range | Recoveryb | Validation | Assay Time | Sample Volume | Preparation | Reference |
---|---|---|---|---|---|---|---|---|---|---|
Cardiac troponin (cTnI) | N-prGO-(py-PEG/Py-COOH=20:1)/GCE | DPV | 1 pg mL−1 | 0.001 – 100 ng mL−1 | N/A | ELFA | N/A | N/A | Whole saliva | (Chekin et al. 2018b) |
Cortisol | GNPs and PS67-b-PAA27 on Whatman filter paper | EIS | 1 pg mL−1 | 1 pg mL−1 – 10 ng mL−1 | N/A | ELISA RE62011 kit R2 = 0.9386 |
10 min | 20 μL | 1:10 dilution | (Khan et al. 2017a) |
Cortisol | GNPs and PS67-b-PAA27 on Whatman filter paper | Chemi-resistive | 3 pg mL−1c | 0.018 – 4.552 ng mL−1c 3 pg mL−1 – 10 μg mL−1d |
N/A | ELISA RE62011 kit R2 = 0.9951 |
12 min | 5 μL | Whole saliva | (Khan et al. 2017b) |
Cortisol | c-Mab conjugated rGO sheet/ITO/glass | Chemi-resistive | 10 pg mL−1 (27.6 pM) | 1 – 10 ng mL−1 | N/A | ELISA | N/A | N/A | 1:1 dilution with buffer solution | (Kim et al. 2017c) |
Cortisol | anti-cortisol antibody/d-BSA/rGO/quartz | EIS | 10 pM | 10 pM – 100 nM | 92 – 103% | N/A | 30 min | 1 mL | Whole saliva | (Kim et al. 2017b) |
Cortisol | BSA/anti-Cab/SAM/CBμE/PS_b_PAA/G RP/Paper | EIS | 0.87 pg mL−1 | 1 pg mL−1 – 10 ng mL−1 | 91 – 113% | ELISA 96.3% accuracy | 12 min | 5 μL | Whole saliva | (Khan et al. 2019) |
Ghrelin (GHRL) | anti-GHRL-Phe-rGO/SPCE | DPV | 1 pg mL−1e | 10−3 – 100 ng/mL | 97% | ELISA LOD = 161 pg/mL | N/A | 3 μL | N/A | (Martínez-García et al. 2016) |
Glucose | CuO/rGO/CNF/GCE | Chronoamperometric | 0.1 μM | 1 μM – 5.3 mM | 99.7 – 101.3% | N/A | 3 s | N/A | 1:10 dilution | (Ye et al. 2013) |
L-tryptophan (Try) | AuNPs/rGO/SPE | DPV | 0.39 μmol/L | 0.5 – 500 μmol/L | 94.6 – 107.6% | N/A | N/A | N/A | Whole saliva | (Nazarpour et al. 2020) |
Myoglobin (Mb) | anti-Mb-Ab/d-BSA/r-HGO/quartz | EIS | 2.37 pM | 5 pM – 10 nM | 90.9–111.3% | N/A | N/A | N/A | Whole saliva | (Yoo et al. 2020) |
Nitrite (NIT) | 3D printed polylactic acid containing graphene (G-PLA) electrodes | DPV BIA-MPA |
BIA-MPA: 0.03 μmol/L DPV: 30 μmol/L |
BIA-MPA: 0.5–250 μmol/L DPV: 50–1300 μmol/L |
100 – 110% | N/A | N/A | N/A | Dilution | (Cardoso et al. 2020) |
Peptide YY (PYY) | anti-PYY-Phe-rGO/SPCE | DPV | 0.02 pg/mLe | 10−4 – 10 ng/mL | 99% | ELISA LOD = 2.84 pg/mL | N/A | 3 μL | N/A | (Martínez-García et al. 2016) |
Serotonin | GO-chitosan modified GSPE | DPV | 3.2 Nm | 0.01 – 100 μM | 104.20% | N/A | 20 min | 10 μL | N/A | (Adumiträchioaie et al. 2019) |
Uric acid (UA) | 3D printed polylactic acid containing graphene (G-PLA) electrodes | DPV BIA-MPA |
BIA-MPA: 0.02 μmol/L DPV: 0.5 μmol/L |
BIA-MPA: 0.5–250 μmol/L DPV: 10–70 μmol/L |
120% | N/A | N/A | N/A | Dilution | (Cardoso et al. 2020) |
S/N = 3, otherwise differently specified
values obtained in real saliva samples, otherwise differently specified
in saliva
in buffer
S/N = 2